These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7569497)

  • 1. Analysis of pseudo-profiles in organ pharmacokinetics and toxicokinetics.
    Mager H; Göller G
    Stat Med; 1995 May 15-30; 14(9-10):1009-24. PubMed ID: 7569497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies.
    Mager H; Göller G
    J Pharm Sci; 1998 Mar; 87(3):372-8. PubMed ID: 9523992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
    Wolfsegger MJ; Jaki T
    J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):479-94. PubMed ID: 19847629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence evaluation of sparse sampling pharmacokinetics data using bootstrap resampling method.
    Shen M; Machado SG
    J Biopharm Stat; 2017; 27(2):257-264. PubMed ID: 27906608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design.
    Bonate PL
    Pharm Res; 1998 Mar; 15(3):405-10. PubMed ID: 9563069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bootstrap method-based estimation of the minimum sample number for obtaining pharmacokinetic parameters in preclinical experiments.
    Takemoto S; Yamaoka K; Nishikawa M; Yano Y; Takakura Y
    J Pharm Sci; 2010 Apr; 99(4):2176-84. PubMed ID: 19902519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.
    Ette EI; Onyiah LC
    Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing bioequivalence in serial sacrifice designs.
    Wolfsegger MJ
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):103-13. PubMed ID: 17053981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An estimation method of the half-life for a one-compartment model of a single bolus intravenous injection by a single sampling.
    Funatogawa T; Funatogawa I; Yafune A
    J Biopharm Stat; 2007; 17(5):827-37. PubMed ID: 17885868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of drug accumulation in the evaluation of pharmacokinetic data.
    Meineke I; Gleiter CH
    J Clin Pharmacol; 1998 Aug; 38(8):680-4. PubMed ID: 9725542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.
    Coe MA; Jufer Phipps RA; Cone EJ; Walsh SL
    J Anal Toxicol; 2018 Jun; 42(5):285-292. PubMed ID: 29462364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
    Haug KG; Weber B; Hochhaus G; Butterweck V
    Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogram analysis of pharmacokinetic parameters by bootstrap resampling from one-point sampling data in animal experiments.
    Takemoto S; Yamaoka K; Nishikawa M; Takakura Y
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):458-64. PubMed ID: 17220561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How critical is the duration of the sampling scheme for the determination of half-life, characterization of exposure and assessment of bioequivalence?
    Colucci P; Turgeon J; Ducharme MP
    J Pharm Pharm Sci; 2011; 14(2):217-26. PubMed ID: 21733410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation and inference in pharmacokinetic models: the effectiveness of model reformulation and resampling methods for functions of parameters.
    Niedzwiecki D; Simonoff JS
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):361-77. PubMed ID: 2231325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.